BFS Syringes Market Outlook (2023 to 2033)

The global BFS syringes market is predicted to exceed a valuation of US$ 878.48 million in 2023. Sales in the BFS syringes market are expected to propel at 9.4% CAGR between 2023 and 2033. As per the study, the top 3 countries are estimated to hold around 35 to 40% of the market in 2023.

Top Market Highlights:

  • Growing demand for BFS syringes in the healthcare and cosmetics industry is expected to augment the growth in the market.
  • The BFS syringes market is projected to rise at 2.4x times the current market value during the forecast period.
  • The preference for advanced pharmaceutical packaging forms and unit dose packaging is driving the demand in the market.
  • Blow fill seal (BFS) technology for prefilled syringes is extensively used in pharmaceutical companies.
  • The use of these syringes for cosmetics products for applications in serums and other skincare products is expected to fuel the demand in the market.
Attributes Key Insights
BFS Syringes Market Size (2023) US$ 878.48 million
Projected Market Size (2033F) US$ 2,158.46 million
Value CAGR (2023 to 2033) 9.4%
Top 3 Countries Market Share 35-40%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of BFS Syringes (2018 to 2022) Vs Demand Forecast (2023 to 2033)

According to Future Market Insights (FMI), the global BFS syringes market secured a CAGR of 8.7% over the historical period from 2018 to 2022 and the market reached US$ 803 million by the end of 2022.

The market for BFS syringes is projected to expand at a significant pace over the forecast period. Blow-fill-seal (BFS) is a sterilized technology utilized for packaging and automated process and is increasingly being adopted by the aseptic packaging industry.

The benefit of blow-fill-seal technology is that it packages in single dosage form, reducing the risk of errors and contamination. In addition, it is used for packaging diagnostic kits, medical devices, tablets, syringes, vaccines, and others. The technology known as blow fill seal (BFS) is used to fill containers with a range of liquids in small and big volumes.

The BFS technology has been approved by FDA (Food and Drug Administration) approval for use in making pharmaceutical and healthcare items using a superior aseptic processing method. Also, the method combines several procedures, such as extrusion, molding, sealing, and filling in a single step without the use of outside assistance.

The fully automatic BFS technology's filling and sealing procedure offers a high level of product and process reliability with precision filling. To cater to this rising demand, manufacturers are expanding their production capacities along with target markets. Backed by these aforementioned factors, the BFS syringes market is expected to increase at a CAGR of 9.4% over the next decade.

Top Trends Propelling the Market Growth

Increasing Demand for Aseptic Packaging Fuelling BFS Syringes Sales

BFS syringes offer a sterile solution and satisfy the requirement for aseptic conditions with the advent of automation in the packaging industry. High accuracy is provided by aseptic packaging employing BFS syringes technology regarding the number of clean products packed per minute.

Syringes are manufactured, filled, and sealed utilizing automated BFS technology in a single process. BFS machinery is suited for single-use dose aseptic and sterilized syringes as it reduces the possibility of extraneous contamination.

BFS technology is frequently employed for the aseptic packing of respiratory, ophthalmic, oral, and pre-filled syringes & injectable medications. These goods do not need refrigeration, making them convenient for buyers and reasonably priced for sellers.

Development in Pharmaceutical Sector Creating Growth Opportunities

Advanced sterilizing techniques are used by leading pharmaceutical manufacturers to reduce operator involvement and the chance of contamination while packaging liquid medications. It is a preferred technology for drug packaging as it offers flexible versatility in packaging design, cost-effectiveness, sterility, and limited component inventory.

The packaging of a wide range of containers is now possible. It is due to the developments in the BFS system, including vials with inserted tips or caps, twist-off re-closable vials, eyewash and contact lens solution bottles, multi-dose use bottles, unit dose syringes & injectables, and sports drink bottles.

The pharmaceutical sector is witnessing an increase in demand for sophisticated aseptic packaging, such as syringes, bottles, vials, and ampoules employing the BFS technology. The market for BFS syringes is therefore expected to expand significantly as a result of the rise in demand for these product categories.

Ismail Sutaria
Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise insights

The United States BFS Syringes Market to Benefit from Growing Demand for Aseptic Packaging

The United States BFS syringe market is anticipated to create an incremental opportunity of US$ 248 million from 2023 to 2033 and is estimated to expand 2.3x the current market value by the end of 2033. According to the Centers for Disease Control and Prevention (CDC), around 76% of the United States population have received at least one dose of COVID vaccine until 8th February 2022.

The demand in the market is projected to spur with the advent of automation in the packaging industry and demand for aseptic packaging in the United States to reduce the risk of contamination. As per FMI, backed by these factors, demand for modified BFS technology syringes is predicted to surge over the forecast period

Germany to be the Sought-after Market in Europe

Germany is a top-tier country concerning pharmaceutical producers. The company also exports an extensive range of medicinal products the world over. Germany is forecasted to sustain its position as a top market for BSF syringe manufacturers. This is further highlighted by the fact that pharmaceutical packaging leaders have set their bases in the country, and they show a penchant for blow-fill-seal technology to sterilize injectable packaging and ampoules.

BFS technique has recently seen high use in the pharmaceutical industry to serve parental preparation with relatively less interference from human beings. This technology is seen as a superior method for aseptic filling of parental preparation by multiple regulatory bodies like the USA Food and Drug Administration (FDA). It is further deployed to fill eye drops, inhalation, infusions, and other parental preparations.

Several advantages of BFS syringes, like low operating cost, flexible packaging design, high degree of sterility, low requirement of laborers, and restricted component inventory, are factored in by pharmaceutical packaging firms.

Injectable packaging has remained the central focus of companies operating in Europe, which is shooting up the market growth trajectory.

The deployment of blow-fill-seal (BFS) technology is surging in the pharmaceutical sector due to the surging demand for advanced aseptic packaging like vials, bottles, ampoules, and pre-filled syringes.

Advances in BFS technology are facilitating the packaging of a great variety of containers like twist-off & re-closeable vials, vials with inserted caps/tips, eyewash & contact lens solution bottles, multi-dose use bottles, electrolyte & sports drinks bottles, and unit dose pre-filled syringes & injectable.

Increasing Sales of Vaccines in India to Boost BFS Syringes Market

According to FMI, demand in India is projected to expand at a CAGR of 10.9% from 2023 to 2033. Rising vaccination consumption in India is predicted to improve the sales of syringes. Also, the high consumption of vaccines has led the key syringes manufacturer to increase their production capacity.

As per the Hindustan Syringes & Medical Devices Ltd (HMD), the manufacturer of the syringes in India achieved the target of producing over 1 billion syringes for COVID vaccination in August 2021.

Category-wise Insights

BFS Polypropylene Syringes to Gain Traction in the BFS Syringes Market

Low-density polyethylene (LDPE), high-density polyethylene (HDPE), and polypropylene (PP) are the polymers most frequently utilized in BFS syringes. As it can be extruded at a low temperature than HDPE or PP, LDPE is frequently used for containers for large-molecule medications or vaccinations.

A low processing temperature makes it simple to get the right surface temperature for filling. Since PP can resist great temperatures during the terminal sterilization procedure, it is extensively used for pharmaceuticals that need to be terminally sterilized.

The flexibility of the packaging is important when it comes to the material and for this PP material is preferred as one of the best choices. They have a unique attachment to the extruder which can allow the mixing of the quantity of the measured colorant. Hence, polypropylene (PE) is expected to generate a CAGR of 9.1% from 2023 to 2033.

BFS Syringes Market to Generate US$ 770 million Revenue in Healthcare & Pharmaceutical Sector

As per FMI, leading pharmaceutical producers, use cutting-edge sterilizing technology to reduce errors and contamination. It is a preferred technology for drug packaging as blow-fill-seal (BFS) technology offers safe and sterile packaging. With the increasing demand for aseptic packaging in the healthcare sector, leading organizations are using such syringes employing the blow-fill-seal (BFS) technology.

The syringes used in healthcare allow to reduce the contamination risk and error of dosage. It also prevents the reuse possibility so that no cross-infection takes place. However, due to the rising demand in pharmaceutical and healthcare segments, it is expected to generate an incremental opportunity of more than US$ 770 million by 2033 for the BFS syringes market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

Key players operating in the BFS syringes market are adopting various mergers and acquisitions to gain a competitive edge in the industry. They are also focusing on new product launches and aseptic packaging to expand their customer base.

Key players are collaborating with pharmaceutical players to offer contract manufacturing services for prefilled syringes, injectables, and ampoules. Key strategies that have remained central to the growth of technology providers include capacity expansion, upgrading, supplementing production, and enhancing operational efficiency.

Collaboration is another go-to strategy implemented by manufacturers vying for a large geographical presence.

Recent Developments

  • In March 2022, Gerresheimer a global leader in the packaging industry took over a new building in Ohio for filling medications with proper hygiene and aseptic packaging.
  • In November 2021, Becton, Dickinson, and Company declared their investment in a new manufacturing facility in Spain which might help the company to increase its capacity for manufacturing pre-fillable syringes.
  • In November 2017, Curida inked a contingency agreement with The Norwegian Armed Forces. This development is aimed at procuring a flexible hold on services and goods while maximizing the raw material prices.
  • In May 2017, Weiler Engineering and Noxilizer came into an exclusive supply agreement for the BFS industry. Under this agreement, Noxilizer intends to deliver NOX FLEX Rapid Biodecontamination units for the latest ASEP-TECH Blow-Fil-Seal systems of Weiler Engineering, Inc. This development is projected to invigorate the company’s product line.

Shanghai Iven, Nipro, and Brevetti at the Forefront of Revolutionizing Healthcare through Blow-Fill-Seal (BFS) Syringes

The healthcare industry’s focus on cost-effectiveness and dosage accuracy has led to innovations in syringe technology. Blow-fill-seal (BFS) syringes are transforming how syringes are packaged and administered.

Leading syringe manufacturers are now steadily switching to BFS technology, and prominent among these manufacturers is Shanghai IVEN Pharmatech Engineering Co. Ltd. The company has a strong presence not only in the BFS syringe technology but also in other healthcare machines and devices such as peritoneal dialysis solutions, vacuum blood collection tubes, syrup washing filling capping, and virus sampling tubes.

Nipro, another leading BFS syringe manufacturer, has a strong focus on consolidating its position through innovation and research, and development. For instance, during the coronavirus pandemic, the company introduced two disposable Dosesaver vaccines that improved the yield of shots considerably. Traditional syringes can administer a shot of 5 shots, whereas the Dosesaver vaccines deliver up to 7 shots.

Nipro is expanding its manufacturing capacity by opening up new units, especially in the Asia Pacific region. For instance, the company has a 150 thousand square meter big facility in Thailand that employs over 7,000 workers. In addition to its strong focus on innovation and technology, Nipro is also committed to sustainability efforts.

Nipro has a goal of reducing its greenhouse gas emissions by 46% by 2030. The company has also installed a 1.50 megawatts solar power generation platform that is capable of generating up to 3.4 MW of power. The company has over 30 factories all over the globe, and it plans to open new units as demand for various types of healthcare devices grows.

A key area of concern for syringe manufacturers is the wear and tear caused due to the friction between syringes and machine parts. To solve this longstanding issue, many companies are focusing on research and development, and innovation.

For instance:

  • In 2020, Brevetti CEA announced a new K15DR machine, capable of operating at a speed of 600 pieces per minute. The new machine is flexible and compatible with liquid, gel, and viscous products. Further, the machine also has a no-contact handling system that effectively reduces any possible friction.

Mergers and acquisitions are a key part of Brevetti’s overall business strategy. The company is boosting its area of expertise through mergers and acquisitions with companies that have the technical know-how. For instance, the company announced the acquisition of Criterion AI in August 2020 to specialize in image-based learning.

Brevetti also acquired Sintech Srl in November 2020 a company specializing in automated machinery. The acquisition is likely to give Brevetti great control over automation and robotics.

Scope of the Report

Attributes Details
Estimated Market Size (2023) US$ 878.48 million
Projected Market Size (2033F) US$ 2,158.46 million
Growth Rate CAGR of 9.4% from 2023 to 2033
Base Year of Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered Capacity, Material Type, End Use, Region
Regions Covered North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania
Key Countries Profiled The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia
Key Companies Profiled IVEN Pharmatech Engineering Co., Ltd.; Brevetti Angela S.R.L; OPTIMA Packaging Group GmbH; Vanrx, AST, Inc; B. Braun Melsungen; Nipro; Takeda Pharmaceuticals International AG; Nephron Pharmaceuticals Corporation; Horizon Pharmaceutical Inc; Recipharm AB; Laboratorios SALVAT, S.A; The Ritedose Corporation; Unicep Packaging, LLC; Pharmapack Co. Ltd; Amanta Healthcare Ltd.; Automatic Liquid Packaging Solutions LLC; Asept Pak, Inc; SIFI Spa; Unither Pharmaceuticals SAS; LyondellBasell Industries N.V.

Global BFS Syringes Market by Category

By Capacity:

  • 0.5-1 ml
  • 1-3 ml
  • Above 3 ml

By Material Type:

  • Polypropylene (PP)
  • Polyvinyl Chloride (PVC)
  • Others (Polyethylene)

By End Use:

  • Pharmaceuticals and Healthcare
  • Personal Care and Cosmetics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia
  • South Asia
  • Oceania

Frequently Asked Questions

How Has the Market Developed in the Past?

From 2018 to 2022, the global market exhibited 8.7% CAGR.

What is the Prominent Growth Driver of the Market?

Growing demand in the healthcare and cosmetics industry is the growth driver.

Who are the Market Players?

Asept Pak, Inc., SIFI Spa, and Nipro are the market players.

Which Country has the Dominant Market Share?

The United States has the dominant market share.

What is the Key Trend of the Market?

Development in the pharmaceutical sector creates growth opportunities.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Introduction / Key Findings
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity, 2023 to 2033
        6.3.1. 0.5-1 ml
        6.3.2. 1-3 ml
        6.3.3. Above 3 ml
    6.4. Y-o-Y Growth Trend Analysis By Capacity, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Capacity, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material Type, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material Type, 2023 to 2033
        7.3.1. Polypropylene (PP)
        7.3.2. Polyvinyl Chloride (PVC)
        7.3.3. Others
    7.4. Y-o-Y Growth Trend Analysis By Material Type, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By Material Type, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022
    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033
        8.3.1. Pharmaceuticals and Healthcare
        8.3.2. Personal Care and Cosmetics
        8.3.3. Others
    8.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
    8.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Capacity
        10.2.3. By Material Type
        10.2.4. By End Use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Capacity
        10.3.3. By Material Type
        10.3.4. By End Use
    10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Capacity
        11.2.3. By Material Type
        11.2.4. By End Use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Capacity
        11.3.3. By Material Type
        11.3.4. By End Use
    11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Capacity
        12.2.3. By Material Type
        12.2.4. By End Use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Capacity
        12.3.3. By Material Type
        12.3.4. By End Use
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Capacity
        13.2.3. By Material Type
        13.2.4. By End Use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Capacity
        13.3.3. By Material Type
        13.3.4. By End Use
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Capacity
        14.2.3. By Material Type
        14.2.4. By End Use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Capacity
        14.3.3. By Material Type
        14.3.4. By End Use
    14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Capacity
        15.2.3. By Material Type
        15.2.4. By End Use
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Capacity
        15.3.3. By Material Type
        15.3.4. By End Use
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Capacity
        16.2.3. By Material Type
        16.2.4. By End Use
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Capacity
        16.3.3. By Material Type
        16.3.4. By End Use
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
    17.2. 17.1.2.2. By Capacity
    17.3. 17.1.2.3. By Material Type
    17.4. 17.1.2.4. By End Use
    17.5. Canada
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
    17.6. 17.2.2.2. By Capacity
    17.7. 17.2.2.3. By Material Type
    17.8. 17.2.2.4. By End Use
    17.9. Brazil
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
    17.10. 17.3.2.2. By Capacity
    17.11. 17.3.2.3. By Material Type
    17.12. 17.3.2.4. By End Use
    17.13. Mexico
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
    17.14. 17.4.2.2. By Capacity
    17.15. 17.4.2.3. By Material Type
    17.16. 17.4.2.4. By End Use
    17.17. Germany
        17.17.1. Pricing Analysis
        17.17.2. Market Share Analysis, 2022
    17.18. 17.5.2.2. By Capacity
    17.19. 17.5.2.3. By Material Type
    17.20. 17.5.2.4. By End Use
    17.21. UK
        17.21.1. Pricing Analysis
        17.21.2. Market Share Analysis, 2022
    17.22. 17.6.2.2. By Capacity
    17.23. 17.6.2.3. By Material Type
    17.24. 17.6.2.4. By End Use
    17.25. France
        17.25.1. Pricing Analysis
        17.25.2. Market Share Analysis, 2022
    17.26. 17.7.2.2. By Capacity
    17.27. 17.7.2.3. By Material Type
    17.28. 17.7.2.4. By End Use
    17.29. Spain
        17.29.1. Pricing Analysis
        17.29.2. Market Share Analysis, 2022
    17.30. 17.8.2.2. By Capacity
    17.31. 17.8.2.3. By Material Type
    17.32. 17.8.2.4. By End Use
    17.33. Italy
        17.33.1. Pricing Analysis
        17.33.2. Market Share Analysis, 2022
    17.34. 17.9.2.2. By Capacity
    17.35. 17.9.2.3. By Material Type
    17.36. 17.9.2.4. By End Use
    17.37. Poland
        17.37.1. Pricing Analysis
        17.37.2. Market Share Analysis, 2022
    17.38. 17.10.2.2. By Capacity
    17.39. 17.10.2.3. By Material Type
    17.40. 17.10.2.4. By End Use
    17.41. Russia
        17.41.1. Pricing Analysis
        17.41.2. Market Share Analysis, 2022
    17.42. 17.11.2.2. By Capacity
    17.43. 17.11.2.3. By Material Type
    17.44. 17.11.2.4. By End Use
    17.45. Czech Republic
        17.45.1. Pricing Analysis
        17.45.2. Market Share Analysis, 2022
    17.46. 17.12.2.2. By Capacity
    17.47. 17.12.2.3. By Material Type
    17.48. 17.12.2.4. By End Use
    17.49. Romania
        17.49.1. Pricing Analysis
        17.49.2. Market Share Analysis, 2022
    17.50. 17.13.2.2. By Capacity
    17.51. 17.13.2.3. By Material Type
    17.52. 17.13.2.4. By End Use
    17.53. India
        17.53.1. Pricing Analysis
        17.53.2. Market Share Analysis, 2022
    17.54. 17.14.2.2. By Capacity
    17.55. 17.14.2.3. By Material Type
    17.56. 17.14.2.4. By End Use
    17.57. Bangladesh
        17.57.1. Pricing Analysis
        17.57.2. Market Share Analysis, 2022
    17.58. 17.15.2.2. By Capacity
    17.59. 17.15.2.3. By Material Type
    17.60. 17.15.2.4. By End Use
    17.61. Australia
        17.61.1. Pricing Analysis
        17.61.2. Market Share Analysis, 2022
    17.62. 17.16.2.2. By Capacity
    17.63. 17.16.2.3. By Material Type
    17.64. 17.16.2.4. By End Use
    17.65. New Zealand
        17.65.1. Pricing Analysis
        17.65.2. Market Share Analysis, 2022
    17.66. 17.17.2.2. By Capacity
    17.67. 17.17.2.3. By Material Type
    17.68. 17.17.2.4. By End Use
    17.69. China
        17.69.1. Pricing Analysis
        17.69.2. Market Share Analysis, 2022
    17.70. 17.18.2.2. By Capacity
    17.71. 17.18.2.3. By Material Type
    17.72. 17.18.2.4. By End Use
    17.73. Japan
        17.73.1. Pricing Analysis
        17.73.2. Market Share Analysis, 2022
    17.74. 17.19.2.2. By Capacity
    17.75. 17.19.2.3. By Material Type
    17.76. 17.19.2.4. By End Use
    17.77. South Korea
        17.77.1. Pricing Analysis
        17.77.2. Market Share Analysis, 2022
    17.78. 17.20.2.2. By Capacity
    17.79. 17.20.2.3. By Material Type
    17.80. 17.20.2.4. By End Use
    17.81. GCC Countries
        17.81.1. Pricing Analysis
        17.81.2. Market Share Analysis, 2022
    17.82. 17.21.2.2. By Capacity
    17.83. 17.21.2.3. By Material Type
    17.84. 17.21.2.4. By End Use
    17.85. South Africa
        17.85.1. Pricing Analysis
        17.85.2. Market Share Analysis, 2022
    17.86. 17.22.2.2. By Capacity
    17.87. 17.22.2.3. By Material Type
    17.88. 17.22.2.4. By End Use
    17.89. Israel
        17.89.1. Pricing Analysis
        17.89.2. Market Share Analysis, 2022
    17.90. 17.23.2.2. By Capacity
    17.91. 17.23.2.3. By Material Type
    17.92. 17.23.2.4. By End Use
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Capacity
        18.3.3. By Material Type
        18.3.4. By End Use
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. IVEN Pharmatech Engineering Co., Ltd.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
                19.1.1.5.2. Product Strategy
                19.1.1.5.3. Channel Strategy
        19.1.2. Brevetti Angela S.R.L
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
                19.1.2.5.2. Product Strategy
                19.1.2.5.3. Channel Strategy
        19.1.3. OPTIMA Packaging Group GmbH
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
                19.1.3.5.2. Product Strategy
                19.1.3.5.3. Channel Strategy
        19.1.4. Vanrx, AST, Inc
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
                19.1.4.5.2. Product Strategy
                19.1.4.5.3. Channel Strategy
        19.1.5. B. Braun Melsungen
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
                19.1.5.5.2. Product Strategy
                19.1.5.5.3. Channel Strategy
        19.1.6. Nipro
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
                19.1.6.5.2. Product Strategy
                19.1.6.5.3. Channel Strategy
        19.1.7. Takeda Pharmaceuticals International AG
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
                19.1.7.5.2. Product Strategy
                19.1.7.5.3. Channel Strategy
        19.1.8. Nephron Pharmaceuticals Corporation
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
                19.1.8.5.2. Product Strategy
                19.1.8.5.3. Channel Strategy
        19.1.9. Horizon Pharmaceutical Inc
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
                19.1.9.5.2. Product Strategy
                19.1.9.5.3. Channel Strategy
        19.1.10. Recipharm AB
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
                19.1.10.5.2. Product Strategy
                19.1.10.5.3. Channel Strategy
        19.1.11. Laboratorios SALVAT, S.A
            19.1.11.1. Overview
            19.1.11.2. Product Portfolio
            19.1.11.3. Profitability by Market Segments
            19.1.11.4. Sales Footprint
            19.1.11.5. Strategy Overview
                19.1.11.5.1. Marketing Strategy
                19.1.11.5.2. Product Strategy
                19.1.11.5.3. Channel Strategy
        19.1.12. The Ritedose Corporation
            19.1.12.1. Overview
            19.1.12.2. Product Portfolio
            19.1.12.3. Profitability by Market Segments
            19.1.12.4. Sales Footprint
            19.1.12.5. Strategy Overview
                19.1.12.5.1. Marketing Strategy
                19.1.12.5.2. Product Strategy
                19.1.12.5.3. Channel Strategy
        19.1.13. Unicep Packaging, LLC
            19.1.13.1. Overview
            19.1.13.2. Product Portfolio
            19.1.13.3. Profitability by Market Segments
            19.1.13.4. Sales Footprint
            19.1.13.5. Strategy Overview
                19.1.13.5.1. Marketing Strategy
                19.1.13.5.2. Product Strategy
                19.1.13.5.3. Channel Strategy
        19.1.14. Pharmapack Co. Ltd
            19.1.14.1. Overview
            19.1.14.2. Product Portfolio
            19.1.14.3. Profitability by Market Segments
            19.1.14.4. Sales Footprint
            19.1.14.5. Strategy Overview
                19.1.14.5.1. Marketing Strategy
                19.1.14.5.2. Product Strategy
                19.1.14.5.3. Channel Strategy
        19.1.15. Amanta Healthcare Ltd.
            19.1.15.1. Overview
            19.1.15.2. Product Portfolio
            19.1.15.3. Profitability by Market Segments
            19.1.15.4. Sales Footprint
            19.1.15.5. Strategy Overview
                19.1.15.5.1. Marketing Strategy
                19.1.15.5.2. Product Strategy
                19.1.15.5.3. Channel Strategy
        19.1.16. Automatic Liquid Packaging Solutions LLC
            19.1.16.1. Overview
            19.1.16.2. Product Portfolio
            19.1.16.3. Profitability by Market Segments
            19.1.16.4. Sales Footprint
            19.1.16.5. Strategy Overview
                19.1.16.5.1. Marketing Strategy
                19.1.16.5.2. Product Strategy
                19.1.16.5.3. Channel Strategy
        19.1.17. Asept Pak, Inc
            19.1.17.1. Overview
            19.1.17.2. Product Portfolio
            19.1.17.3. Profitability by Market Segments
            19.1.17.4. Sales Footprint
            19.1.17.5. Strategy Overview
                19.1.17.5.1. Marketing Strategy
                19.1.17.5.2. Product Strategy
                19.1.17.5.3. Channel Strategy
        19.1.18. SIFI Spa
            19.1.18.1. Overview
            19.1.18.2. Product Portfolio
            19.1.18.3. Profitability by Market Segments
            19.1.18.4. Sales Footprint
            19.1.18.5. Strategy Overview
                19.1.18.5.1. Marketing Strategy
                19.1.18.5.2. Product Strategy
                19.1.18.5.3. Channel Strategy
        19.1.19. Value (US$ Million) & Volume (Units)her Pharmaceuticals SAS
            19.1.19.1. Overview
            19.1.19.2. Product Portfolio
            19.1.19.3. Profitability by Market Segments
            19.1.19.4. Sales Footprint
            19.1.19.5. Strategy Overview
                19.1.19.5.1. Marketing Strategy
                19.1.19.5.2. Product Strategy
                19.1.19.5.3. Channel Strategy
        19.1.20. LyondellBasell Industries N.V
            19.1.20.1. Overview
            19.1.20.2. Product Portfolio
            19.1.20.3. Profitability by Market Segments
            19.1.20.4. Sales Footprint
            19.1.20.5. Strategy Overview
                19.1.20.5.1. Marketing Strategy
                19.1.20.5.2. Product Strategy
                19.1.20.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Recommendations

Healthcare

Industry Analysis of Syringe and Needle in GCC

March 2024

REP-GC-1874

324 pages

Healthcare

Retractable Needle Safety Syringes Market

July 2023

REP-GB-15450

324 pages

Explore Packaging Insights

View Reports
Future Market Insights

BFS Syringes Market

Schedule a Call